Carcinogenesis, drug-inducedMethotrexate, adverse reactions - serious
Kaposi's sarcoma, non-Hodgkin's lymphoma, Hodgkin's disease, and squamous cell carcinoma are among the malignancies seen with increased frequency in patients infected with HIV. The outlook for patients with these malignancies has improved significantly with the utilization of highly active antiretroviral...
The treatment of Hodgkin lymphoma has improved dramatically over the last 20 years, with advances in imaging techniques. In the early stages, this cancer of the immune system can be cured with a 95 percent success rate by a combination of radiation and chemotherapy. The major challenge is ...
Hodgkin\"s Lymphoma in an Elite Endurance Athlete The article presents a case report which illustrates the physical performance of a world-class endurance athlete who was diagnosed with advanced-stage Hodgkin's lymphoma. Before the diagnosis, the athlete was advised to make a complete p... YO ...
Carcinogenesis, drug-inducedMethotrexate, adverse reactions - serious
Azathioprine, adverse reactions - seriousCyclophosphamide, adverse reactions - seriousImmunosuppressants, adverse reactions - seriousMycophenolate-mofetil, adverse reactions - seriousNon-Hodgkin's-lymphoma, drug-inducedPrednisone, adverse reactions - serious...
Iodine-131-tositumomab, therapeutic useNon-Hodgkin's-lymphoma, treatment
Lymphoma, treatmentRituximab, therapeutic use
Bendamustine, therapeutic useNon-Hodgkin's-lymphoma, treatment
AUTHORS' CONCLUSIONS: Rituximab maintenance therapy should be added to standard therapy of patients with relapsed or refractory follicular lymphoma following a successful induction treatment. The drug should be given either as four weekly infusions every six months or as a single infusion every two to...